176 results on '"Leon, Leticia G."'
Search Results
2. The tumor suppressor MIR139 is silenced by POLR2M to promote AML oncogenesis
3. Double Trouble: A Case Series on Concomitant Genetic Aberrations in NSCLC
4. TABLE 3 from Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case–Control Study
5. TABLE 4 from Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case–Control Study
6. FIGURE 1 from Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case–Control Study
7. Supplementary Figure 1 from Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case–Control Study
8. TABLE 7 from Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case–Control Study
9. Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case–Control Study
10. TABLE 5 from Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case–Control Study
11. Supplementary Figure 2 from Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case–Control Study
12. TABLE 6 from Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case–Control Study
13. Data from Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case–Control Study
14. FIGURE 2 from Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case–Control Study
15. TABLE 2 from Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case–Control Study
16. TABLE 1 from Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case–Control Study
17. Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas:A Nested Case-Control Study
18. Supplementary Methods from MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
19. Supplementary Figures 1-5 from MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
20. Data from MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
21. Supplementary Video from MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
22. Abstract A004: Molecular adenoma features to predict metachronous colorectal cancer risk: A nested-case control study
23. Antiproliferative and quinone reductase-inducing activities of withanolides derivatives
24. Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model
25. Derivatives of grindelic acid: From a non-active natural diterpene to synthetic antitumor derivatives
26. Molecular Mechanisms Underlying the Antitumor Activity of 3-Aminopropanamide Irreversible Inhibitors of the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer
27. β-Lapachone analogs with enhanced antiproliferative activity
28. Enhancement of antiproliferative activity by molecular simplification of catalpol
29. Antiproliferative activity of synthetic naphthoquinones related to lapachol. First synthesis of 5-hydroxylapachol
30. miR-181a is a novel player in the STAT3-mediated survival network of TCRαβ+ CD8+ T large granular lymphocyte leukemia
31. Tessaric acid derivatives induce G 2/M cell cycle arrest in human solid tumor cell lines
32. Proteomic Analysis of Mesenchymal Stromal Cell-Derived Extracellular Vesicles and Reconstructed Membrane Particles
33. The tumor suppressor MIR139 is silenced by POLR2M to promote AML oncogenesis
34. FireDB: a compendium of biological and pharmacologically relevant ligands
35. The miR-200c/141-ZEB2-TGFβ axis is aberrant in human T-cell prolymphocytic leukemia
36. Association between DNA-repair polymorphisms and survival in pancreatic cancer patients treated with combination chemotherapy
37. Heatr9 is an infection responsive gene that affects cytokine production in alveolar epithelial cells
38. Rapid in vitro generation of bona fide exhausted CD8+ T cells is accompanied by Tcf7 promotor methylation
39. Establishment And Application of An in Vitro Cd8+ T Cell Exhaustion System
40. Identification of a core miRNA signature unique to exhausted cytotoxic CD8+ T cells
41. Glucocorticoid Resistant Pediatric Acute Lymphoblastic Leukemia Samples Display Altered Splicing Profile and Vulnerability to Spliceosome Modulation
42. In vitro generation of mature neutrophils from canine Lin− bone marrow cells
43. Lung transcriptional unresponsiveness and loss of early influenza virus control in infected neonates is prevented by intranasal Lactobacillus rhamnosus GG
44. Responsiveness of chronic lymphocytic leukemia cells to B-cell receptor stimulation is associated with low expression of regulatory molecules of the nuclear factor-κB pathway
45. The tumor suppressor MIR139is silenced by POLR2M to promote AML oncogenesis
46. Fatigue in Sjögren's Syndrome: A Search for Biomarkers and Treatment Targets
47. Abstract 2466: A comprehensive genome-wide analysis of small noncoding RNAs in T-cell prolymphocytic leukemia
48. Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model
49. Molecular simplification in bioactive molecules: Formal synthesis of (+)-muconin
50. Development of bioluminescent chick chorioallantoic membrane (CAM) models from primary pancreatic cancer cells: A platform for drug testing
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.